Copernicus Capital Management, LLC
- SEC CIK
- 0001694620
- Latest filing
- Nov 15, 2021
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 11
- −3 vs. Q1 2021
- Portfolio value
- $6.34M
- +$152.0K (+2.5%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | 9,000 | $1.81M | 28.6% | +6,000+200.0% | Added | History |
| FATEFate Therapeutics Inc | COM | 10,000 | $868.0K | 13.7% | +2,000+25.0% | Added | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 50,000 | $778.0K | 12.3% | +50,000 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 10,000 | $532.0K | 8.4% | +10,000 | New | History |
| TCRRTCR2 Therapeutics Inc. | COM | 30,000 | $492.0K | 7.8% | +30,000 | New | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 5,000 | $468.0K | 7.4% | +5,000 | New | History |
| ACCDAccolade, Inc. | COM | 7,000 | $380.0K | 6.0% | +7,000 | New | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 2,000 | $355.0K | 5.6% | +2,000 | New | History |
| GRTSGritstone bio, Inc. | COM | 35,000 | $320.0K | 5.0% | −2,000−5.4% | Reduced | History |
| SKINSkinHealth Systems Inc. | COM CL A | 10,000 | $168.0K | 2.6% | +10,000 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 20,000 | $165.0K | 2.6% | +10,000+100.0% | Added | History |
Sold out since Q1 2021 (10)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| BMRNBiomarin Pharmaceutical Inc | COM | 10,000 | $755.0K | 12.2% | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 1,500 | $710.0K | 11.5% | History |
| ABBVAbbVie Inc. | Stock | 6,000 | $649.0K | 10.5% | History |
| RVMDRevolution Medicines, Inc. | COM | 10,000 | $459.0K | 7.4% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 8,000 | $355.0K | 5.7% | History |
| TGTXTG Therapeutics, Inc. | COM | 7,000 | $337.0K | 5.4% | History |
| ARDXArdelyx, Inc. | COM | 50,000 | $331.0K | 5.3% | History |
| BCELAtreca, Inc. | CL A COM | 18,000 | $276.0K | 4.5% | History |
| TDOCTeladoc Health, Inc. | COM | 1,500 | $273.0K | 4.4% | History |
| ORTXOrchard Therapeutics plc | ADS | 15,000 | $109.0K | 1.8% | History |